These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9871658)

  • 21. [Antibacterial activity of tosufloxacin against fresh clinical isolates].
    Yamashiro Y; Shimakura M; Minami S; Fukuoka Y; Yasuda T; Watanabe Y; Narita H; Akama M
    Jpn J Antibiot; 1994 Mar; 47(3):245-54. PubMed ID: 8182895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
    Pucci MJ; Cheng J; Podos SD; Thoma CL; Thanassi JA; Buechter DD; Mushtaq G; Vigliotti GA; Bradbury BJ; Deshpande M
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1259-67. PubMed ID: 17242152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro antimicrobial activity of hydroxypyridinone hexadentate-based dendrimeric chelators alone and in combination with norfloxacin.
    Zhou YJ; Zhang MX; Hider RC; Zhou T
    FEMS Microbiol Lett; 2014 Jun; 355(2):124-30. PubMed ID: 24813898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of E-3846, a new fluoroquinolone, against gram-negative and gram-positive bacteria.
    Moros M; Coll R; Esteve M; Parés J; Xicota MA
    Chemioterapia; 1987 Jun; 6(2 Suppl):149-51. PubMed ID: 3509373
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibacterial activity of a new tetracyclic quinolone, No. 5290, against norfloxacin- and ciprofloxacin-resistant strains of Staphylococcus aureus.
    Kotera Y; Inoue Y; Ohashi M; Ito K; Tsukamoto G
    Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2644-6. PubMed ID: 1666861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vitro evaluation of lomefloxacin].
    Dette GA; Knothe H
    Arzneimittelforschung; 1989 Aug; 39(8):832-5. PubMed ID: 2818672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro antibacterial activity of DX-619, a novel des-fluoro(6) quinolone.
    Fujikawa K; Chiba M; Tanaka M; Sato K
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3040-5. PubMed ID: 15980395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-vitro activity of new sulphanilil fluoroquinolones against Staphylococcus aureus.
    Allemandi DA; Alovero FL; Manzo RH
    J Antimicrob Chemother; 1994 Aug; 34(2):261-5. PubMed ID: 7814287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-vitro selection of bacteria resistant to the 4-quinolone agents.
    Limb DI; Dabbs DJ; Spencer RC
    J Antimicrob Chemother; 1987 Jan; 19(1):65-71. PubMed ID: 3470281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of temafloxacin hydrochloride (TA-167 or A-62254), a new fluorinated 4-quinolone.
    Nakanishi N; Inoue M; Inoue K; Yamaguchi T; Mitsuhashi S
    Chemotherapy; 1990; 36(5):345-55. PubMed ID: 2209168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteoadsorptive bisphosphonate derivatives of fluoroquinolone antibacterials.
    Herczegh P; Buxton TB; McPherson JC; Kovács-Kulyassa A; Brewer PD; Sztaricskai F; Stroebel GG; Plowman KM; Farcasiu D; Hartmann JF
    J Med Chem; 2002 May; 45(11):2338-41. PubMed ID: 12014972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A facile solid-state synthesis and in vitro antimicrobial activities of some 2,6-diarylpiperidin/tetrahydrothiopyran and tetrahydropyran-4-one oximes.
    Gopalakrishnan M; Thanusu J; Kanagarajan V
    J Enzyme Inhib Med Chem; 2009 Jun; 24(3):669-75. PubMed ID: 18830879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on prodrugs. 7. Synthesis and antimicrobial activity of 3-formylquinolone derivatives.
    Kondo H; Sakamoto F; Kawakami K; Tsukamoto G
    J Med Chem; 1988 Jan; 31(1):221-5. PubMed ID: 3275778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on prodrugs. 11. Synthesis and antimicrobial activity of N-[(4-methyl-5-methylene-2-oxo-1,3-dioxolan-4-yl)oxy]norfloxacin .
    Kondo H; Sakamoto F; Uno T; Kawahata Y; Tsukamoto G
    J Med Chem; 1989 Mar; 32(3):671-4. PubMed ID: 2645402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of nadifloxacin against methicillin-resistant Staphylococcus aureus isolated from skin infections: comparative study with seven other fluoroquinolones.
    Nishijima S; Nakagawa M; Tsuboi N; Akamatsu H; Horio T; Fujita M; Kawabata S
    J Int Med Res; 1996; 24(1):12-6. PubMed ID: 8674789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of PD127,391, a new quinolone against bacterial isolates from cancer patients.
    Rolston KV; Ho DH; LeBlanc B; Bodey GP
    Chemotherapy; 1990; 36(5):365-72. PubMed ID: 2209169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibacterial properties of AM-1155, a new 8-methoxy quinolone.
    Hosaka M; Kinoshita S; Toyama A; Otsuki M; Nishino T
    J Antimicrob Chemother; 1995 Aug; 36(2):293-301. PubMed ID: 8522459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo antibacterial activities of DW-224a, a new fluoronaphthyridone.
    Park HS; Kim HJ; Seol MJ; Choi DR; Choi EC; Kwak JH
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2261-4. PubMed ID: 16723601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and antimicrobial evaluation of some new substituted purine derivatives.
    Tunçbilek M; Ateş-Alagöz Z; Altanlar N; Karayel A; Ozbey S
    Bioorg Med Chem; 2009 Feb; 17(4):1693-700. PubMed ID: 19150600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-vitro activity of trovafloxacin against clinical bacterial isolates from patients with cancer.
    Rolston KV; Ho DH; LeBlanc B; Streeter H; Dvorak T
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():15-22. PubMed ID: 9222065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.